Home›People›Daniel Shelly
DS

Daniel Shelly

Board of Directors at BioSolution Designs.

Director
Updated Nov 11, 2026·Latest SEC filing Mar 12, 2026·Suggest an edit

About Daniel Shelly

Daniel Shelly is a board of directors at BioSolution Designs.

Experience

This experience comes from Daniel Shelly's profile and from SEC filings. For roles taken from filings, the years are when the filings name Daniel Shelly in the role, so the role may have started earlier or lasted longer.

Immuthera Current
Chief Business Development Officer
2025 – Present
PolTREG S.A. Current
Chief Business Development Officer
2024 – Present
BioSolution Designs, Inc. Current
Board of Directors - BioSolutions Designs
2021 – Present · Frederick, MD
Develops and licenses biotechnology tools for companies developing therapies.
BioStem Technologies (OTC: BSEM)
Scientific Advisory Board Member
2021 – 2025
Prescient Therapeutics
Vice President Business Development and Alliances
2020 – 2024
PATH
Director Global Business Development and Strategic Partnerships, Essential Medicines
2019 – 2020
Albumedix
Director Business Development
2016 – 2020
Novozymes Biopharma
Director Business Development
2011 – 2016
Meridian Life Science, Inc.
Director, Business Development
2004 – 2011
Kendle International
Sr. Regulatory Affairs Specialist
2001 – 2003
Emerging Concepts Inc
Consultant
1999 – 2001

Key Colleagues at Startups

The people Daniel Shelly works with at each company, as listed on that company's latest Form D.

BioSolution Designs, Inc. · Form D, Mar 12, 2026
TR
Thomas Reed
Founder & CEO, director
JM
John Maslowski
Board of Directors

Sources

  1. SECBioSolution Designs, Inc. Form D, filed Mar 12, 2026